Roy et al. established an innovative in vitro MMD model using CRISPR-Cas9-mediated RNF213 gene knockout and illustrated an enhanced secretion of soluble pro-angiogenic factors and significant increase in angiogenesis in confluent ECs devoid of RNF213 expression [13]. Here, RNF213 is linked to multiminicore myopathy.